Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep | 38 | 2023 | 444 | 5.280 |
Why?
|
| Sleep Deprivation | 22 | 2023 | 137 | 4.400 |
Why?
|
| Circadian Rhythm | 21 | 2023 | 303 | 3.800 |
Why?
|
| Sleep Apnea, Obstructive | 19 | 2021 | 219 | 3.670 |
Why?
|
| Blood Glucose | 22 | 2021 | 873 | 3.130 |
Why?
|
| Obesity | 22 | 2020 | 963 | 2.900 |
Why?
|
| Diabetes Mellitus, Type 2 | 19 | 2021 | 1373 | 2.890 |
Why?
|
| Sleep Wake Disorders | 15 | 2023 | 115 | 2.540 |
Why?
|
| Insulin Resistance | 12 | 2018 | 377 | 1.880 |
Why?
|
| Continuous Positive Airway Pressure | 3 | 2016 | 53 | 1.190 |
Why?
|
| Chronobiology Disorders | 2 | 2016 | 3 | 1.070 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 5 | 2019 | 50 | 1.050 |
Why?
|
| Sleep, REM | 8 | 2014 | 50 | 1.050 |
Why?
|
| Hydrocortisone | 13 | 2020 | 298 | 0.970 |
Why?
|
| Human Growth Hormone | 7 | 2016 | 54 | 0.930 |
Why?
|
| Glycerides | 2 | 2020 | 17 | 0.860 |
Why?
|
| Arachidonic Acids | 2 | 2020 | 39 | 0.860 |
Why?
|
| Endocannabinoids | 2 | 2020 | 27 | 0.850 |
Why?
|
| Diabetes, Gestational | 2 | 2013 | 39 | 0.850 |
Why?
|
| Polysomnography | 17 | 2017 | 151 | 0.810 |
Why?
|
| Circadian Clocks | 3 | 2021 | 53 | 0.770 |
Why?
|
| Insulin | 9 | 2017 | 1160 | 0.730 |
Why?
|
| Melatonin | 5 | 2023 | 47 | 0.680 |
Why?
|
| Wakefulness | 6 | 2016 | 134 | 0.660 |
Why?
|
| Humans | 81 | 2023 | 86645 | 0.650 |
Why?
|
| Diabetes Mellitus | 6 | 2015 | 806 | 0.610 |
Why?
|
| Adult | 44 | 2023 | 25648 | 0.600 |
Why?
|
| Male | 52 | 2023 | 40967 | 0.590 |
Why?
|
| Risk Factors | 19 | 2021 | 5417 | 0.570 |
Why?
|
| Neurosecretory Systems | 3 | 2008 | 35 | 0.540 |
Why?
|
| Prediabetic State | 4 | 2021 | 39 | 0.520 |
Why?
|
| Blood Pressure | 6 | 2021 | 1143 | 0.510 |
Why?
|
| Appetite | 4 | 2009 | 26 | 0.510 |
Why?
|
| Disease Outbreaks | 2 | 2008 | 154 | 0.500 |
Why?
|
| Glucocorticoids | 1 | 2017 | 352 | 0.500 |
Why?
|
| Time Factors | 16 | 2019 | 5210 | 0.490 |
Why?
|
| Leptin | 3 | 2020 | 105 | 0.480 |
Why?
|
| Female | 42 | 2023 | 44534 | 0.480 |
Why?
|
| Polycystic Ovary Syndrome | 3 | 2011 | 203 | 0.480 |
Why?
|
| Health Status | 4 | 2005 | 360 | 0.470 |
Why?
|
| Aging | 4 | 2005 | 691 | 0.470 |
Why?
|
| Glucose Tolerance Test | 9 | 2019 | 228 | 0.470 |
Why?
|
| Glucose Intolerance | 2 | 2011 | 96 | 0.470 |
Why?
|
| Occupational Diseases | 1 | 2014 | 55 | 0.460 |
Why?
|
| Hormones | 2 | 2009 | 141 | 0.410 |
Why?
|
| Middle Aged | 30 | 2023 | 25028 | 0.410 |
Why?
|
| Sleep Stages | 3 | 2010 | 45 | 0.410 |
Why?
|
| Hypnotics and Sedatives | 1 | 2012 | 125 | 0.400 |
Why?
|
| Young Adult | 14 | 2023 | 5976 | 0.390 |
Why?
|
| Autonomic Nervous System | 3 | 2016 | 56 | 0.390 |
Why?
|
| Metabolism | 1 | 2010 | 24 | 0.380 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 336 | 0.370 |
Why?
|
| Affect | 2 | 2015 | 386 | 0.370 |
Why?
|
| Pregnancy Outcome | 1 | 2011 | 247 | 0.360 |
Why?
|
| Inpatients | 2 | 2016 | 297 | 0.360 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 334 | 0.350 |
Why?
|
| Testosterone | 1 | 2011 | 271 | 0.350 |
Why?
|
| Cardiovascular Diseases | 3 | 2021 | 827 | 0.340 |
Why?
|
| Brain | 3 | 2017 | 2216 | 0.340 |
Why?
|
| Glucose | 6 | 2021 | 638 | 0.330 |
Why?
|
| Growth Hormone | 3 | 2005 | 97 | 0.320 |
Why?
|
| Case-Control Studies | 4 | 2020 | 1805 | 0.300 |
Why?
|
| Aged | 21 | 2023 | 18415 | 0.300 |
Why?
|
| Dietary Carbohydrates | 2 | 2010 | 38 | 0.290 |
Why?
|
| Hunger | 2 | 2016 | 23 | 0.290 |
Why?
|
| Delta Rhythm | 1 | 2005 | 19 | 0.270 |
Why?
|
| Pituitary-Adrenal System | 3 | 2017 | 64 | 0.270 |
Why?
|
| Critical Illness | 3 | 2023 | 294 | 0.270 |
Why?
|
| Epinephrine | 1 | 2005 | 84 | 0.270 |
Why?
|
| Cross-Sectional Studies | 8 | 2021 | 1621 | 0.260 |
Why?
|
| Surveys and Questionnaires | 6 | 2019 | 2501 | 0.250 |
Why?
|
| Fasting | 5 | 2016 | 161 | 0.250 |
Why?
|
| Peptide Hormones | 1 | 2004 | 29 | 0.250 |
Why?
|
| Cardiography, Impedance | 1 | 2004 | 4 | 0.240 |
Why?
|
| Vaccination | 2 | 2023 | 254 | 0.240 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 2 | 2015 | 13 | 0.230 |
Why?
|
| Electroencephalography | 5 | 2017 | 709 | 0.230 |
Why?
|
| Body Mass Index | 5 | 2017 | 770 | 0.230 |
Why?
|
| Congresses as Topic | 2 | 2021 | 116 | 0.220 |
Why?
|
| Adolescent | 11 | 2023 | 8982 | 0.220 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2017 | 350 | 0.220 |
Why?
|
| Cross-Over Studies | 6 | 2017 | 399 | 0.210 |
Why?
|
| Vaccines | 1 | 2023 | 80 | 0.210 |
Why?
|
| Influenza Vaccines | 1 | 2002 | 142 | 0.200 |
Why?
|
| Meals | 1 | 2021 | 22 | 0.200 |
Why?
|
| Research Report | 1 | 2021 | 44 | 0.200 |
Why?
|
| Antibodies, Viral | 1 | 2002 | 293 | 0.200 |
Why?
|
| Aged, 80 and over | 6 | 2023 | 6509 | 0.190 |
Why?
|
| Energy Metabolism | 3 | 2015 | 271 | 0.190 |
Why?
|
| Hospitalization | 2 | 2016 | 849 | 0.190 |
Why?
|
| Fatigue | 2 | 2011 | 174 | 0.180 |
Why?
|
| Exercise | 1 | 2003 | 315 | 0.180 |
Why?
|
| Prevalence | 4 | 2014 | 1239 | 0.170 |
Why?
|
| Prospective Studies | 7 | 2017 | 4213 | 0.170 |
Why?
|
| Glomerular Filtration Rate | 2 | 2017 | 384 | 0.170 |
Why?
|
| Heart Rate | 2 | 2016 | 492 | 0.170 |
Why?
|
| Thyroid Diseases | 1 | 2019 | 104 | 0.170 |
Why?
|
| Phototherapy | 1 | 2018 | 35 | 0.160 |
Why?
|
| Attention | 1 | 2003 | 388 | 0.160 |
Why?
|
| Social Class | 1 | 1999 | 128 | 0.160 |
Why?
|
| Ghrelin | 2 | 2010 | 29 | 0.160 |
Why?
|
| Jet Lag Syndrome | 4 | 2019 | 13 | 0.160 |
Why?
|
| Thyroid Gland | 1 | 2019 | 270 | 0.160 |
Why?
|
| Habits | 1 | 2017 | 15 | 0.150 |
Why?
|
| Hyperglycemia | 2 | 2016 | 176 | 0.150 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2017 | 44 | 0.150 |
Why?
|
| Poverty | 1 | 1999 | 173 | 0.150 |
Why?
|
| Animals | 9 | 2021 | 26582 | 0.150 |
Why?
|
| Carbohydrate Metabolism | 2 | 2008 | 30 | 0.150 |
Why?
|
| Treatment Outcome | 4 | 2017 | 7993 | 0.150 |
Why?
|
| Time | 1 | 2016 | 77 | 0.140 |
Why?
|
| Norepinephrine | 1 | 2016 | 167 | 0.140 |
Why?
|
| Hyperphagia | 1 | 2016 | 35 | 0.140 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2016 | 83 | 0.140 |
Why?
|
| Pregnancy | 2 | 2013 | 2894 | 0.130 |
Why?
|
| Hormone Replacement Therapy | 2 | 2013 | 77 | 0.130 |
Why?
|
| Comorbidity | 3 | 2015 | 943 | 0.130 |
Why?
|
| Lighting | 2 | 2012 | 32 | 0.120 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2008 | 81 | 0.120 |
Why?
|
| Sex Factors | 4 | 2010 | 1054 | 0.120 |
Why?
|
| Actigraphy | 4 | 2017 | 51 | 0.120 |
Why?
|
| Snoring | 2 | 2017 | 12 | 0.120 |
Why?
|
| Cognition Disorders | 1 | 2015 | 236 | 0.120 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2013 | 70 | 0.120 |
Why?
|
| Hypopituitarism | 1 | 2013 | 19 | 0.110 |
Why?
|
| Biomarkers | 2 | 2023 | 1718 | 0.110 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 190 | 0.110 |
Why?
|
| Energy Intake | 1 | 2013 | 98 | 0.110 |
Why?
|
| Brain Waves | 1 | 2013 | 32 | 0.110 |
Why?
|
| Health Status Disparities | 1 | 2015 | 170 | 0.110 |
Why?
|
| Motor Activity | 1 | 2015 | 327 | 0.110 |
Why?
|
| Administration, Intravenous | 1 | 2012 | 50 | 0.110 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 2017 | 131 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 509 | 0.110 |
Why?
|
| Cohort Studies | 5 | 2019 | 2767 | 0.110 |
Why?
|
| Logistic Models | 2 | 2016 | 1187 | 0.110 |
Why?
|
| Hypertension | 3 | 2014 | 1141 | 0.100 |
Why?
|
| Healthy Volunteers | 3 | 2017 | 143 | 0.100 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2011 | 66 | 0.100 |
Why?
|
| Adipocytes | 1 | 2012 | 155 | 0.100 |
Why?
|
| Blood Pressure Determination | 1 | 2011 | 90 | 0.100 |
Why?
|
| Kidney | 1 | 2017 | 1241 | 0.100 |
Why?
|
| Child | 3 | 2019 | 6928 | 0.100 |
Why?
|
| Thyrotropin | 3 | 2010 | 280 | 0.100 |
Why?
|
| Age Factors | 4 | 2010 | 1851 | 0.090 |
Why?
|
| Electrocardiography | 1 | 2012 | 478 | 0.090 |
Why?
|
| Chronic Disease | 2 | 2007 | 971 | 0.090 |
Why?
|
| Random Allocation | 2 | 2017 | 332 | 0.090 |
Why?
|
| Postprandial Period | 2 | 2010 | 47 | 0.090 |
Why?
|
| Quality of Life | 2 | 2010 | 1585 | 0.090 |
Why?
|
| Prolactin | 2 | 2005 | 88 | 0.090 |
Why?
|
| Intensive Care Units | 1 | 2012 | 374 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 584 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2010 | 227 | 0.080 |
Why?
|
| Vagus Nerve | 2 | 2005 | 45 | 0.080 |
Why?
|
| Inflammation | 1 | 2014 | 920 | 0.080 |
Why?
|
| Metabolic Syndrome | 2 | 2015 | 141 | 0.080 |
Why?
|
| Sympathetic Nervous System | 2 | 2005 | 104 | 0.080 |
Why?
|
| Weight Gain | 1 | 2008 | 123 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2023 | 8491 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2016 | 912 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1801 | 0.070 |
Why?
|
| Acetamides | 1 | 2005 | 26 | 0.070 |
Why?
|
| Alpha Rhythm | 1 | 2005 | 24 | 0.070 |
Why?
|
| Body Temperature | 1 | 2005 | 124 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2006 | 596 | 0.060 |
Why?
|
| Respiratory Mechanics | 1 | 2005 | 102 | 0.060 |
Why?
|
| Homeostasis | 3 | 2015 | 409 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 865 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2007 | 324 | 0.060 |
Why?
|
| Pituitary Gland | 1 | 2004 | 117 | 0.060 |
Why?
|
| Hypoxia | 1 | 2008 | 641 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2023 | 171 | 0.050 |
Why?
|
| Somatoform Disorders | 1 | 2002 | 29 | 0.050 |
Why?
|
| Loneliness | 1 | 2002 | 24 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2004 | 297 | 0.050 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 1981 | 2 | 0.050 |
Why?
|
| Heart | 1 | 2004 | 539 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2008 | 2262 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 456 | 0.050 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 2000 | 7 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 567 | 0.050 |
Why?
|
| Seasons | 1 | 1981 | 223 | 0.040 |
Why?
|
| Geriatric Assessment | 2 | 2015 | 166 | 0.040 |
Why?
|
| Overweight | 1 | 2019 | 118 | 0.040 |
Why?
|
| Incidence | 2 | 2014 | 1577 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2010 | 334 | 0.040 |
Why?
|
| Self Report | 1 | 2019 | 288 | 0.040 |
Why?
|
| Adiposity | 1 | 2017 | 70 | 0.040 |
Why?
|
| Sheep | 1 | 2017 | 239 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 2705 | 0.040 |
Why?
|
| Appetite Regulation | 1 | 2016 | 9 | 0.040 |
Why?
|
| Endophenotypes | 1 | 2015 | 17 | 0.030 |
Why?
|
| Food Deprivation | 1 | 2015 | 24 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 839 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 966 | 0.030 |
Why?
|
| Accelerometry | 1 | 2015 | 36 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 859 | 0.030 |
Why?
|
| Eating | 1 | 2016 | 166 | 0.030 |
Why?
|
| Age of Onset | 1 | 2015 | 310 | 0.030 |
Why?
|
| Wisconsin | 1 | 2014 | 39 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 177 | 0.030 |
Why?
|
| Arousal | 2 | 2008 | 170 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 2015 | 84 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 999 | 0.030 |
Why?
|
| C-Peptide | 1 | 1994 | 174 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2017 | 380 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2017 | 313 | 0.030 |
Why?
|
| Reward | 1 | 2016 | 181 | 0.030 |
Why?
|
| Rats | 1 | 2000 | 3990 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2013 | 153 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 1531 | 0.030 |
Why?
|
| Kinetics | 1 | 1994 | 1513 | 0.030 |
Why?
|
| Length of Stay | 1 | 2015 | 703 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 322 | 0.020 |
Why?
|
| Acylation | 1 | 2010 | 38 | 0.020 |
Why?
|
| Chicago | 1 | 2015 | 1379 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2015 | 376 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2010 | 147 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2010 | 167 | 0.020 |
Why?
|
| Employment | 1 | 2010 | 52 | 0.020 |
Why?
|
| Health Surveys | 1 | 2010 | 239 | 0.020 |
Why?
|
| Life Style | 1 | 2010 | 189 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 674 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1961 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 678 | 0.020 |
Why?
|
| Neoplasms | 1 | 2021 | 2898 | 0.020 |
Why?
|
| Glucaric Acid | 1 | 2005 | 5 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2005 | 63 | 0.020 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2005 | 103 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2005 | 268 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 3241 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 11352 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1981 | 155 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2005 | 1823 | 0.010 |
Why?
|
| Health Behavior | 1 | 2002 | 183 | 0.010 |
Why?
|
| Students | 1 | 2002 | 147 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2002 | 306 | 0.010 |
Why?
|
| United States | 1 | 2010 | 6674 | 0.010 |
Why?
|